| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.24▲ | 7.14▲ | 7.07▲ | 6.67▲ | 5.49▲ |
| MA10 | 7.19▲ | 6.99▲ | 6.71▲ | 6.02▲ | 4.28▲ |
| MA20 | 7.12▲ | 6.63▲ | 6.61▲ | 5.65▲ | 3.37▲ |
| MA50 | 6.90▲ | 6.53▲ | 6.21▲ | 4.11▲ | 2.45▲ |
| MA100 | 6.64▲ | 6.02▲ | 5.97▲ | 3.26▲ | 2.67▲ |
| MA200 | 6.33▲ | 5.39▲ | 4.41▲ | 2.51▲ | 2.87▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | 0.071▲ | 0.073▲ | 0.112▲ | 0.420▲ |
| RSI | 76.271▲ | 75.023▲ | 72.995▲ | 71.830▲ | 80.309▲ |
| STOCH | 93.788▲ | 97.505▲ | 93.374▲ | 82.471▲ | 46.237 |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | 0.000▲ | -64.521 |
| CCI | 131.072▲ | 101.084▲ | 129.751▲ | 130.240▲ | 128.240▲ |
|
Thursday, November 13, 2025 03:30 AM
Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused ...
|
|
Wednesday, November 12, 2025 01:20 PM
Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage ...
|
|
Monday, November 10, 2025 10:06 PM
As of Monday, November 10, Armata Pharmaceuticals, Inc.’s ARMP share price has surged by 15.05%, which has investors questioning if this is right time to sell.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 6.38 | 7.32 | 6.00 | 7.32 | 149,600 |
| 13/11/25 | 6.34 | 6.55 | 6.05 | 6.38 | 84,979 |
| 12/11/25 | 6.70 | 6.93 | 6.41 | 6.69 | 106,500 |
| 11/11/25 | 6.22 | 6.76 | 6.13 | 6.75 | 103,900 |
| 10/11/25 | 6.01 | 6.89 | 5.81 | 6.21 | 226,200 |
| 07/11/25 | 5.69 | 5.90 | 5.41 | 5.78 | 125,500 |
| 06/11/25 | 5.58 | 5.93 | 5.40 | 5.74 | 89,311 |
| 05/11/25 | 4.90 | 6.36 | 4.90 | 5.66 | 317,863 |
| 04/11/25 | 4.68 | 5.03 | 4.66 | 4.84 | 65,400 |
| 03/11/25 | 4.90 | 4.90 | 4.65 | 4.83 | 45,400 |
|
|
||||
|
|
||||
|
|